| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.804 | 6.202 | 39.084 | 48.045 | 100.170 | 93.762 |
| Total Income - EUR | - | - | - | - | 4.804 | 6.202 | 39.084 | 48.732 | 100.170 | 94.354 |
| Total Expenses - EUR | - | - | - | - | 647 | 1.338 | 6.335 | 14.846 | 17.601 | 25.679 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.156 | 4.864 | 32.749 | 33.886 | 82.569 | 68.675 |
| Net Profit/Loss - EUR | - | - | - | - | 4.012 | 4.678 | 32.358 | 33.399 | 81.568 | 66.666 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Rx Partner Consultants S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 880 | 515 | 478 | 18.704 | 16.084 | 11.695 |
| Current Assets | - | - | - | - | 3.883 | 4.451 | 32.676 | 52.366 | 71.423 | 70.082 |
| Inventories | - | - | - | - | 291 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 5.015 | 27.088 | 25.705 | 58.125 |
| Cash | - | - | - | - | 3.593 | 4.451 | 27.661 | 25.278 | 45.718 | 11.957 |
| Shareholders Funds | - | - | - | - | 4.054 | 4.728 | 32.407 | 33.448 | 81.616 | 66.714 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 709 | 238 | 748 | 37.622 | 5.891 | 15.062 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Rx Partner Consultants S.r.l.